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Abstract
Background: Proper estimation of sample size requirements for cluster-based studies requires
estimates of the intra-cluster correlation coefficient (ICC) for the variables of interest.
Methods: We calculated the ICC for 112 variables measured as part of the Vermont Diabetes
Information System, a cluster-randomized study of adults with diabetes from 73 primary care
practices (the clusters) in Vermont and surrounding areas.
Results: ICCs varied widely around a median value of 0.0185 (Inter-quartile range: 0.006, 0.037).
Some characteristics (such as the proportion having a recent creatinine measurement) were highly
associated with the practice (ICC = 0.288), while others (prevalence of some comorbidities and
complications and certain aspects of quality of life) varied much more across patients with only
small correlation within practices (ICC<0.001).
Conclusion: The ICC values reported here may be useful in designing future studies that use
clustered sampling from primary care practices.
Background
Multi-level or clustered sampling designs are increasingly
deployed in medical and health care surveys. In these
designs, clusters are identified (e.g. medical practices) and
then subjects (e.g. patients) are sampled from each cluster.
The analysis and sample size estimation for such designs
must take the clustering into account or the resultant sig-
nificance tests (P values) and confidence intervals will be
in error [1]. Generally, failure to account for clustering
leads to nominal confidence intervals that are too narrow
and to P  values that are too small. To the extent that
patient characteristics are independent of cluster, the
effective sample size will be close to the number of indi-
vidual subjects studied. If the subject characteristics are
highly associated within clusters, the effective sample size
approaches the number of clusters. In the extreme case, if
all the subjects within a cluster are identical, there is no
advantage to measuring more than one subject per cluster.
To estimate statistical power or required sample size in a
study based on simple random sampling or allocation,
one requires an estimate of the minimal important effect
and (for continuous measures) the standard deviation of
the outcome in the population studied. For clustered
designs, however, one must also inflate the sample size to
account for the clustering effect. The design effect, some-
times referred to as the variance inflation factor, is a func-
tion of the extent of correlation within clusters, the
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intraclass (or intra-cluster) correlation coefficient (ICC).
Unfortunately, pre-study estimates of ICC are difficult to
come by and obtaining them constitutes "the main diffi-
culty in calculating sample size for cluster randomized
studies" [2].
Several groups have published estimates of ICCs for vari-
ous patient characteristics observed in large surveys of
patients clustered within primary care or general practices
from around the world [3-6]. Here we expand their esti-
mates to include those derived from a survey of adults
with diabetes clustered within primary care practices in
the northeast United States.
Methods
This study was part of a larger project, the Vermont Diabe-
tes Information System (VDIS), a cluster-randomized trial
of a laboratory-based diabetes decision support system in
a region-wide sample of 8808 adults with diabetes from
73 Primary Care practices in Vermont and nearby parts of
the United States [7]. Primary care in these predominantly
rural practices is provided by General Internists, Family
Physicians, Physician Assistants, and Nurse Practitioners
who provide the bulk of long-term care for these and
other patients. There are few diabetes specialists in the
region and most diabetes care is provided in the practices.
All 119 eligible primary care practices near the thirteen
participating hospitals were invited to participate [7]. The
participating practices range in size from one provider (in
41 practices) to two practices with six providers each.
A field survey targeted at a sub-sample of subjects was
designed to provide a better understanding of the non-
laboratory features of the patients before intervention.
Field survey subjects were selected at random from the
patients participating in the VDIS and invited by tele-
phone to participate in an in-home interview. Patient
names were randomly sorted and patients contacted until
a sample of approximately 15% of the patients from each
practice agreed to an interview. We attempted to contact
4,209 patients and reached 1,576 (37%). Of these, 1,006
(64%) agreed to be interviewed.
Subjects who agreed were mailed a questionnaire and
were scheduled for an interview by a trained field inter-
viewer. During the visit, the interviewer reviewed any
missing or ambiguous questionnaire items. If necessary,
the interviewer read the questions aloud for subjects and
recorded their responses for them. Then the interviewer
measured the subject as described below and adminis-
tered a few more instruments that were not included in
the questionnaire. The interviews took place during the
baseline phase of the study before any interventions were
in place. All subjects provided written informed consent.
The protocol was approved by the institutional review
board of the University of Vermont.
Demographic, social and economic characteristics
Income was recorded in seven ordered self-reported cate-
gories from less than US$15,000 per year to US$100,000
per year or more. Education was also recorded as the high-
est level completed in seven categories from "Less than
9th Grade" to "Graduate or Professional Degree." We col-
lapsed self-reported race and ethnicity into two categories:
Non-Hispanic white and all others. Marital status was col-
lapsed into two categories: Married or living as married vs.
all others (single, widowed, divorced or separated). We
recorded the presence or absence of four types of health
insurance: private (commercial indemnity or health
maintenance organization benefits often supplied by an
employer), Medicare (government health coverage for the
elderly and disabled), Medicaid (government health cov-
erage for low income patients), and military (including
active duty or veteran's benefits). Subjects may have more
than one insurance type.
The shortest driving distance from the patients' homes to
their site of care was calculated in kilometers using
ArcView 3.3 by Environmental Systems Research Institute,
Inc., and a geographic data set purchased from TeleAtlas,
Inc. Driving distance was defined as the shortest distance
along roads and highways [8].
Physical characteristics
Height was measured using a portable stadiometer (SECA,
Inc.), weight with a portable scale (LB Dial Scale
HAP200KD-41, Healthometer, Inc.), and blood pressure
with an automated sphygmomanometer (Omron Model
HEM-711). Blood pressure was obtained in the seated
position in the left arm (unless contraindicated), using
the cuff size recommended by the manufacturer. Three
readings were obtained at 5-minute intervals and were
averaged for the final result. Body mass index was calcu-
lated as weight in kilograms divided by height in meters
squared.
Laboratory results
Glycosolated hemoglobin A1C was measured at 13 clini-
cal laboratories in the patients' home communities. All
laboratories used the same high-pressure liquid chroma-
tography method with identical reference ranges. Serum
creatinine, urine microalbumin-to-creatinine ratio, total
cholesterol, high density lipoprotein cholesterol, and trig-
lycerides were likewise measured by the laboratories. Low
density lipoprotein cholesterol (LDL) was calculated
using the Friedwald formula (LDL = Total cholesterol -
high density lipoprotein cholesterol - triglycerides/5) [9]
from fasting specimens. Each patient was classified as
being above or below certain laboratory value thresholdsBMC Medical Research Methodology 2006, 6:20 http://www.biomedcentral.com/1471-2288/6/20
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recommended by the American Diabetes Association
(A1C >8%; A1C <7%; microalbumin-to-creatinine ratio
<30 mg/mmol) [10]. If the LDL was 100 mg/dl or greater,
or if it could not be calculated because the triglycerides
were above 400 mg/dl, we categorized lipids as above
goal. Tests were ordered by the primary care provider
when clinically indicated. We report the most recent labo-
ratory assays done before the home visit.
Quality of care
Where possible, we classified each subject as meeting or
not meeting recommendations for care made by the
American Diabetes Association [10] and the Vermont Pro-
gram for Quality in Health Care [11]. Creatinine and
urine microalbumin tests were due every year. A1C was on
time if the latest test was within 3 months (6 months if the
latest result was <7.0%). Lipid testing was on time if the
latest test was within 6 months (12 months if the latest
result showed LDL-cholesterol under 100 mg/dl). Addi-
tional measures indicate if the subject was both on time
and had results on target for A1C and LDL. Pneumonia
vaccine was recommended once ever. Influenza vaccine
was considered up to date if the patient reported it was
given in the current or previous calendar year.
Health habits
Alcohol consumption was measured by asking: "How
many drinks of the following alcoholic beverages do you
have in a typical week (including weekends)?
Bottles or cans of beer: _________
Glasses of wine or wine coolers: _________
Mixed drinks or shots of liquor: _________"
Subjects who indicated that they do not currently drink
alcohol were assigned zero to each of the three beverage
categories. A summary variable representing total con-
sumption was constructed as the sum of the three bever-
age-specific responses. Subjects were also asked the four
CAGE screening questions [12].
Tobacco use was assessed by asking: "Have you smoked a
cigarette – even one puff – during the past seven days?"
Those responding "yes" were asked "How many cigarettes
do you smoke on an average day?"
Self care
We assessed self-care behavior with the Summary of Dia-
betes Self Care Activities Measure [13]. This instrument
asks the subject to record how many days in the last week
they performed recommended self-care activities such as
following a healthful eating plan, or participating in at
least 30 minutes of physical activity. Eleven items are used
to generate 5 summary scores representing the fraction of
days the subject performs recommended activities related
to general diet, diabetes-specific diet, exercise, blood glu-
cose self-monitoring, and foot care. Each score ranges
from 0 to 100.
Literacy
The Short Test of Functional Health Literacy in Adults
(STOFHLA) is a 7-minute timed instrument that measures
the ability to read health-related material [14,15]. The
score ranges from 0 to 36 items answered correctly.
Responses can be categorized at "inadequate" (STOFHLA
0–16), "marginal" (STOFHLA 17–22), and "adequate"
(STOFHLA 23–36).
Comorbidity
The Self-Administered Comorbidity Questionnaire is a
modification of the widely used Charlson Index. It uses
patient interview or questionnaire responses rather than
chart abstraction for assessment of comorbidity and has
excellent agreement with the chart-based Charlson Index
[16,17]. We calculated the rate of endorsement of each of
18 specific conditions as well the number of conditions
endorsed. We also calculated a score with one point if the
condition is endorsed and additional points if the subject
reports currently receiving treatment for it, or if it limits
activities. Each condition may, therefore, contribute 0 to 3
points for a possible maximum of 54 points. One of the
conditions, "eye, nerve, or kidney damage due to diabe-
tes" may be considered a complication of diabetes rather
than strictly a comorbidity.
Functional status and depression
The Medical Outcomes Trust SF-12 Health Survey is a
widely used, validated instrument for assessment of gen-
eral (rather than disease-specific) functional status [18].
Two summary scales are calculated: the Physical Compo-
nent Summary and the Mental Component Summary.
The Patient Health Questionnaire-9 is a brief self-report
instrument that quantifies the presence and degree of
mental depression [19].
Complications
We assessed the presence of diabetes complications by
asking six questions. The responses were "Yes," "No," and
"Don't know."
1. Have you ever had an ulcer or sore on your leg or foot
that took more than 4 weeks to heal?
Has your doctor or health care provider ever told you that
you have these problems:
2. Problems with vision or retinopathy related to your dia-
betes?BMC Medical Research Methodology 2006, 6:20 http://www.biomedcentral.com/1471-2288/6/20
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3. Pain, burning, or numbness in the feet or legs related to
your diabetes?
4. Problems with stomach emptying related to your diabe-
tes?
5. Problems with sexual function?"
6. Problems with your kidneys related to your diabetes?
Medications
The subjects were asked to produce "all medications you
have used in the past month including prescriptions, over-
the-counter products, vitamins, and herbs." The field
assistant recorded the name, strength, dose, route, and fre-
quency of each preparation.
Quality of life
The Audit of Diabetes-Dependant Quality of Life is an 18-
item questionnaire regarding the impact of diabetes on
specific aspects of a person's life with patient weighting of
the impact of each domain [20,21]. We employed 17 of
the 18 domains of this instrument. The scores for each
domain can range from -9 (maximum negative impact of
diabetes on that domain) to +9 (maximum positive
impact).
Resource utilization
The survey included items asking the subjects to record
whether they had used various services in the last year:
Endocrinologist, Dietician, Podiatrist, Diabetes Educator,
Ophthalmologist, and Diabetes Class. Those answering
"Don't Know" were assigned a value of "No." It also
prompted subjects to report the number of Emergency
Room visits they had in the last year and "In the past
month, how many times have you been to a doctor or
health care professional?"
Statistical analyses
In the random effects model, the ICC is the proportion of
the total variance that is between clusters (practices).
where   is the between-cluster component of variance
while   is the within-cluster component. If a measure-
ment varies across patients without regard to which prac-
tice they are in, the ICC will be close to zero. If the value
of the variable is largely a function of which practice they
are in, the ICC will be close to 1.0 [2]. We used the analy-
sis of variance estimator [22-24] provided by the "lone-
way" command in STATA 8.2 (Stata Corp., College
Station, Texas). This estimator uses the F statistic to calcu-
late the ICC for N total subjects in k groups of size No:
where
Further,
is the asymptomatic standard error of the ICC, and the
100(1-α)% confidence interval is:
For each characteristic, we recorded the sample size (N),
the sample size per cluster (No) the mean (or proportion
for dichotomous variables), the standard deviation (SD)
for continuous variables, the standard error of the mean
(or percentage) adjusted for clustering within practices
(SE), the ICC, and the 95% confidence interval of the ICC.
We assessed the association between the value (reported
proportion) of binary variables and the ICC [25] with
Spearman's non-parametric correlation coefficient. For
proportions greater than 0.5, we used the complement of
the proportion so that all proportions for this analysis
were less than 0.5. To compare groups of ICCs, we used
the two-sample Wilcoxon rank-sum (Mann-Whitney) test.
Results
The results appear in Table 1. The 112 ICCs ranged from
0 for 15 variables with negative values truncated at zero to
0.288 for the proportion with a creatinine measurement
on time. The median value was 0.0185 with an inter-quar-
tile range of (0.006, 0.037). Results were similar for 62
binary variables (median 0.022; IQR 0.006, 0.040) and 50
continuous variables (median 0.017; IQR 0.006, 0.032).
A Wilcoxon rank-sum test gave a P value of 0.54 for the
comparison between ICCs of continuous and binary vari-
ables.
The ICCs for the 62 binary variables were significantly
associated with their proportions (Spearman's correlation
coefficient = 0.53; P < 0.0001) to a degree sometimes clas-
sified as "Large" [26].
Discussion
These data provide estimates of intra-cluster correlations
for 112 patient characteristics relevant to the analysis of
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Table 1: Descriptive statistics and intra-practice correlation coefficients
Variable NN o Mean or percent SD SE ICC 95% confidence interval
Demographic, social and economic characteristics
Sex (% male) 8808 119.7 48.4 1.3 0.038 0.021, 0.056
Age (years) 8286 117.3 63.1 13.9 0.5 0.077 0.045, 0.109
Married (%) 1004 14.5 62.5 1.6 0.009 0, 0.036
High School Graduate (%) 999 14.4 75.4 1.6 0.011 0, 0.038
Income <$30,000 per year (%) 931 13.4 59.0 2.1 0.042 0.003, 0.081
Private insurance (%) 1001 14.4 58.4 2.0 0.050 0.011, 0.090
Medicare (%) 997 14.4 59.9 1.7 0.018 0, 0.047
Medicaid (%) 995 14.3 21.4 1.8 0.036 0, 0.071
Military or veterans' insurance (%) 994 14.3 5.2 0.8 0.029 0, 0.062
No insurance (%) 993 14.3 2.4 0.6 0.035 0, 0.070
Travel distance from home to Primary Care provider (km) 2955 76.5 13.7 15.3 1.8 0.196 0.102, 0.289
Non-Hispanic white (%) 1004 14.5 97.3 0.5 0.003 0, 0.028
Physical characteristics
Heart Rate (beats per min) 998 14.4 75.0 13.0 0.5 0.015 0, 0.043
Systolic blood pressure (mmHg) 999 14.4 140.3 19.6 0.8 0.042 0.005, 0.079
Diastolic blood pressure (mmHg) 999 14.4 78.3 10.5 0.4 0.017 0, 0.047
Blood pressure below 130/80 mmHg (%) 999 14.4 25.0 1.6 0.028 0, 0.061
Blood pressure over 140/90 mmHg (%) 999 14.4 49.2 2.3 0.069 0.024, 0.114
Height (cm) 998 14.4 165.2 10.4 0.4 0.019 0, 0.048
Weight (kg) 997 14.4 203.0 47.7 1.6 0.011 0, 0.038
Body Mass Index (kg/m2) 994 14.3 33.8 7.4 0.2 0.011 0, 0.039
Body Mass Index >30 kg/m2 (%) 994 14.3 67.2 1.6 0.010 0, 0.038
Laboratory results
Mean glycosolated hemoglobin (A1C) (%) 8711 118.4 7.01 1.45 0.05 0.055 0.032, 0.079
A1C >8.0% (%) 8711 118.4 18.1 1.0 0.025 0.013, 0.037
A1C <7.0 (%) 8711 118.4 61.7 1.6 0.046 0.026, 0.066
Total cholesterol (mg/dl) 8167 112.5 184.4 41.8 1.2 0.037 0.020, 0.054
LDL-cholesterol (mg/dl) 7834 111.0 105.8 34.2 1.0 0.045 0.025, 0.065
LDL <100 mg/dl (%) * 7873 111.6 43.8 1.4 0.029 0.020, 0.055
Triglycerides (mg/dl) 7969 109.8 190.5 161.3 3.3 0.014 0.006, 0.022
Serum creatinine (mg/dl) 8474 115.1 1.12 0.70 0.02 0.080 0.048, 0.112
Urine microalbumin to creatinine ratio (mg/mmol) 3039 46.7 47.0 260.7 10.0 0.101 0.051, 0.152
Urine microalbumin to creatinine ratio <30 mg/mmol (%) 3338 49.0 67.3 1.5 0.031 0.011, 0.051B
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Quality of care (Process Measures)
Creatinine on time (%) 8808 119.7 79.4 3.1 0.288 0.203, 0.373
Urine microalbumin to creatinine ratio on time (%) 8808 119.7 24.6 2.3 0.162 0.105, 0.219
A1C on time (%) 8808 119.7 50.7 2.4 0.118 0.074, 0.162
Lipids on time (%) 8808 119.7 70.3 3.0 0.199 0.132, 0.265
A1C on time & <7% (%) 7308 113.2 35.5 1.5 0.040 0.021, 0.060
LDL on time & <100 mg/dl (%) 7308 113.2 31.3 1.4 0.040 0.021, 0.059
Influenza vaccine given (%) 995 14.3 80.5 1.4 0.058 0.016, 0.100
Pneumonia vaccine given (%) 913 13.2 70.6 1.8 0.058 0.014, 0.102
Health habits
Alcoholic drinks per week 988 14.2 1.6 4.5 0.2 0.027 0, 0.060
CAGE score (0–4) 946 13.6 0.2 0.7 0.2 0.009 0, 0.038
Tobacco smoker (%) 1006 14.5 16.9 1.2 0.005 0, 0.030
Cigarettes per day 159 2.6 17.2 11.2 1.0 0.086 0, 0.270
Summary of Diabetes Self Care Activities Measure
General diet score 953 13.7 58.4 33.3 1.2 0.017 0, 0.048
Specific diet score 980 14.1 52.2 23.9 0.8 0.011 0, 0.038
Exercise score 992 14.3 34.6 32.7 1.2 0.029 0, 0.062
Blood glucose self-monitoring score 933 13.5 57.9 38.9 1.5 0.051 0.010, 0.093
Foot care score 990 14.3 44.2 35.5 1.2 0.002 0, 0.026
Literacy: Short Test of Functional Health Literacy in Adults
Test score (0–36 points) 1002 14.4 29.7 9.6 0.3 0.017 0, 0.079
Inadequate (0–16) (%) 1002 14.4 10.5 1.0 0.011 0, 0.039
Adequate (23–36) (%) 1002 14.4 82.9 1.5 0.037 0.002, 0.073
Comorbidity
Congestive heart failure (%) 1006 14.5 17.1 1.4 0.025 0, 0.057
Coronary artery disease (%) 1006 14.5 19.3 1.4 0.024 0, 0.056
Peripheral vascular disease (%) 1006 14.5 8.7 1.0 0.006 0, 0.032
Stroke (%) 1006 14.5 11.7 1.1 0.006 0, 0.032
Dementia (%) † 1006 14.5 0.9 0.3 0 § 0, 0.024
Asthma (%) 1006 14.5 20.2 1.4 0.014 0, 0.043
Arthritis (%) 1006 14.5 14.1 1.1 <0.001 0, 0.024
Peptic ulcer disease (%) 1006 14.5 14.3 1.2 0.012 0, 0.040
Cirrhosis (%) 1006 14.5 1.9 0.3 0 § 0, 0.024
Table 1: Descriptive statistics and intra-practice correlation coefficients (Continued)B
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Paralysis (%) 1006 14.5 3.0 0.6 0.006 0, 0.032
Renal disease (%) 1006 14.5 5.0 0.6 0 § 0, 0.024
Microvascular complications of diabetes (%) 1006 14.5 16.9 1.2 0.012 0, 0.040
Cancer (%) 1006 14.5 11.9 1.0 0 § 0, 0.024
Leukemia (%) † 1006 14.5 0.6 0.2 0 § 0, 0.024
Lymphoma (%) † 1006 14.5 0.5 0.3 0.018 0, 0.048
Metastatic cancer (%) † 1006 14.5 0.7 0.3 0 § 0, 0.024
HIV disease (%) † 1006 14.5 0.1 0.1 0 § 0, 0.024
Depression (%) 1006 14.5 35.0 1.7 0.007 0, 0.033
Comorbid condition count 1006 14.5 1.8 1.7 0.1 0.031 0, 0.065
Self-reported comorbidity questionnaire score (0–54) 1006 14.5 3.6 3.9 0.2 0.032 0, 0.066
Cardiovascular disease (%) 1006 14.5 30.9 1.6 0.018 0, 0.048
Functional status
SF-12 Physical Component Summary score (0–100) 986 14.2 41.2 12.4 0.5 0.028 0, 0.062
SF-12 Mental Component Summary score (0–100) 986 14.2 50.0 10.7 0.4 0.032 0, 0.061
Patient Health Questionnaire-9 depression score (0–27) 591 11.7 4.1 5.0 0.2 0.006 0, 0.044
Complications of diabetes
Foot ulcer (%) 992 14.3 11.3 1.0 0.009 0, 0.036
Vision problems (%) 950 13.7 20.1 1.3 0 § 0, 0.025
Foot or leg pain (%) 943 13.6 30.9 1.8 0.023 0, 0.055
Stomach emptying problems (%) 901 13.0 6.2 0.8 0.003 0, 0.030
Sexual problems (%) 923 13.3 26.4 1.4 0 § 0, 0.026
Kidney problems (%) 490 10.3 9.2 1.4 0.040 0, 0.096
Medications
Insulin (%) 1006 14.5 18.6 1.4 0.014 0, 0.042
Oral hypoglycemic agent (%) 1006 14.5 66.6 1.7 0.022 0, 0.053
Total medication count (0–29) 1006 14.5 8.8 4.5 0.2 0.028 0, 0.061
Prescription medication count (0–24) 1006 14.5 6.7 3.8 0.2 0.055 0.014, 0.095
Non-prescription medication count (0–15) 1006 14.5 2.0 2.4 0.1 0.059 0.017, 0.101
Audit of Diabetes-Dependant Quality of Life
Do physically 985 14.2 -1.9 2.6 0.1 0.001 0, 0.025
Confidence in ability 982 14.2 -2.0 2.7 0.1 0.004 0, 0.030
Motivation 981 14.2 -1.9 2.7 0.1 0 § 0, 0.025
Freedom to eat 985 14.2 -2.8 2.9 0.1 <0.001 0, 0.025
Enjoyment of food 986 14.2 -2.5 2.9 0.1 0 § 0, 0.025
Table 1: Descriptive statistics and intra-practice correlation coefficients (Continued)B
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Future 984 14.2 -0.6 3.8 0.1 0 § 0, 0.025
Freedom to drink 983 14.2 -1.5 2.4 0.1 0 § 0, 0.025
Dependence 982 14.2 -0.6 2.8 0.1 0.004 0, 0.029
Working life 981 14.2 -1.5 2.3 0.1 0.014 0, 0.042
Family life 985 14.2 -0.6 2.7 0.1 0.035 0, 0.070
Social life 983 14.2 -0.9 2.0 0.1 0 § 0, 0.025
Sex life 978 14.1 -1.0 2.4 0.1 0.020 0, 0.051
Physical appearance 980 14.1 -1.1 2.3 0.1 0.012 0, 0.041
Holidays/Leisure 983 14.2 -1.5 2.5 0.1 0 § 0, 0.025
Travel 981 14.1 -1.6 2.6 0.1 0.022 0, 0.054
Society reaction 977 14.1 -0.5 1.6 0.1 0.026 0, 0.058
Finances 978 14.1 -1.7 2.7 0.1 0.009 0, 0.037
Average weighted impact 990 14.3 -1.5 2.0 0.1 0.004 0, 0.029
Resource utilization
Endocrinologist in last year (%) 971 14.0 15.9 2.0 0.089 0.037, 0.140
Dietician in last year (%) 984 14.2 34.3 1.8 0.018 0, 0.048
Podiatrist in last year (%) 984 14.2 23.8 1.6 0.022 0, 0.054
Diabetes Educator in last year (%) 970 14.0 23.8 1.8 0.041 0.004, 0.078
Ophthalmologist in last year (%) 944 13.6 60.4 2.1 0.041 0.003, 0.079
Diabetes class in last year (%) 999 14.4 35.0 1.9 0.035 0.002, 0.073
Emergency Room visits in last year (mean) 994 14.3 0.64 1.46 0.05 0.015 0, 0.044
Health professional visits in last month (mean) 991 14.3 1.63 2.39 0.08 0.035 0, 0.070
N = Subjects analyzed; No = Number per cluster; SD = standard deviation of mean; SE = standard error adjusted for clustering; ICC = Intra-cluster (intra-practice) correlation coefficient.
*In 39 cases in which LDL could not be estimated because triglycerides were over 400 mg/dl, LDL was assumed to be over 100 mg/dl.
† Because only a few subjects have this condition, the ICC may not be estimated consistently.
§The method used truncates the estimate of ICC (and its CI) at 0 for some values that may be negative.
Table 1: Descriptive statistics and intra-practice correlation coefficients (Continued)BMC Medical Research Methodology 2006, 6:20 http://www.biomedcentral.com/1471-2288/6/20
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adults with diabetes receiving primary care in Vermont
and nearby regions of the United States. They may use-
fully be applied to the design and sample size estimation
of future surveys that are clustered on primary care prac-
tices.
In the design of clustered-based studies, the ICC may be
used to calculate the design effect which is the degree to
which the sample size must be inflated above that of a
simple random sample to account for the loss of informa-
tion inherent in the clustered design. If the average
number of subjects sampled per cluster is m, the design
effect is given by:
Design effect = 1 + (m-1)·ICC
If m or ICC is large, the total number of individual sub-
jects needed may be substantially greater than suggested
by a sample size calculation that is not adjusted for clus-
tering. Alternatively, if both m  and ICC are small, the
design effect may be very close to 1.0 indicating that the
clustered design does not inflate the sample size.
In the VDIS, the cost of enrolling subjects for laboratory
data collection within a cluster, once the practice was
enrolled, was relatively low. Therefore, large values of m
(120.7 subjects per practice on average) were not prob-
lematic. However, the cost per patient of obtaining inter-
view data was relatively high. Therefore, we reduced the
mean sample size per cluster to 14.5 by random sampling
within practice. The design effects experienced in VDIS are
not representative of those faced in other designs unless
they happen to have the same mean cluster sample size as
VDIS (which is extremely unlikely). Therefore, unlike pre-
vious publications, we have elected not to report design
effects. Study designers should use the ICCs and their own
estimates of m to understand their own design effects.
Campbell et al [27] suggest that ICCs are higher for proc-
ess measures than for outcomes. We see evidence for this
in that the eight quality of care variables (process meas-
ures, see Table 1) have a median ICC of 0.088 (IQR 0.049,
0.181) while the ten laboratory outcomes measures have
a median ICC of 0.038 (IQR 0.029, 0.055). This difference
is significant by Wilcoxon rank-sum test with P = 0.013.
We note that the nine physical characteristics of the sub-
jects, presumably under less control of the provider than
either laboratory results or even process measures, have a
median ICC of 0.017 (IQR 0.011, 0.028) and are signifi-
cantly different than the laboratory measures (P = 0.034).
Within practice correlation was most prominent for proc-
ess measures associated with quality of care. The likeli-
hood of receiving a creatinine measurement on time had
the highest ICC (0.288) with other quality of care meas-
ures also among the most highly correlated. This may rep-
resent that process measures are heavily influenced by the
practice style of the practitioners and any office-based pro-
cedures (reminders, registries, flow sheets, etc.) that only
some practices employ. In a similar vein, physiologic con-
trol of some aspects of diabetes (especially achievement of
tight control of A1C and LDL) appears to vary importantly
across practices with ICCs of 0.046 for A1C below 7% and
0.029 for LDL below 100 mg/dl.
Some demographic aspects of the population were corre-
lated within practices: age, sex, and especially travel bur-
den. As patients tend to stay with their primary provider
as they age, some practices accumulate older patients (ICC
= 0.077). Some patients express a preference for same-sex
providers, with more women visiting practices that have
female providers. This may account for the relatively high
ICC for sex (0.038). Travel distance may be related to the
geographic location of the practice office. Practices in
more densely populated areas may tend to have lower typ-
ical travel burdens.
With the possible exception of blood pressure (which may
be under the control of the providers to some degree), the
physical characteristics and health habits of patients vary
little across practices.
Although apparently under the control of the providers,
the utilization of health care services had generally small
ICCs. The exception was consultation by an Endocrinolo-
gist with an ICC of 0.089. This may reflect the geographic
proximity of an endocrinologist to some of the practices.
The aspects of diabetes that are most directly experienced
by patients (complications, quality of life, functional sta-
tus, comorbidity, and self-care) vary little across practices.
It does not appear that some primary care practices tend
to accumulate more complicated or difficult patients than
others. Likewise, low health literacy is a substantial, and
perhaps unrecognized, problem for all practices, with lit-
tle clustering within practices.
These data demonstrate a large correlation between the
proportion of the 62 binary variables and their ICCs. This
finding has been noted by others [25] and may be useful
in estimating an ICC for sample size calculations.
For many of these variables, the impact of within-cluster
correlation on sample size requirements appears to be rel-
atively small. Thirty-three variables had an ICC <0.010
with a design effect less than 1.14 indicating that the VDIS
clustered design required an increase in sample size of
14% compared to a non-clustered study. However,
depending on the number of clusters and the number ofBMC Medical Research Methodology 2006, 6:20 http://www.biomedcentral.com/1471-2288/6/20
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subjects per cluster, even small ICCs can result in the need
for costly increases in overall sample size.
These estimates of ICC are not useful for studies that clus-
ter on factors other than practice (such as community,
hospital, individual provider, family, classroom, etc.). The
VDIS study population was drawn from Vermont and
nearby New York and New Hampshire and is, therefore,
predominantly white and rural. All the subjects were
under care for diabetes. Although some have Type 1 dia-
betes, this older, overweight population is largely com-
prised of patients with Type 2 diabetes. The practices in
the VDIS are small with a median of 2 providers per prac-
tice. For these reasons, generalization to other popula-
tions and settings may be problematic.
Several recent reports provide some comparisons from
other settings (Table 2). A study of British patients aged 75
and older reported intra-practice correlations from 106
general practices [4]. A study from Rhode Island and
nearby Massachusetts enrolled 15 primary care practices
[5]. Several surveys of general practices from Australia and
New Zealand provided a few ICCs comparable to VDIS
[3,6]. The ICCs for most of these variables vary substan-
tially across the studies. For instance, the ICCs for weight
and body mass index varied between 0.011 and 0.081.
Differences in the practice structures, referral patterns,
social and geographic factors and practice patterns may
explain these differences. Only recently have determi-
nants of ICC begun to be studied [26-28]. We suggest that
more catalogues of ICCs, drawn from a variety of settings,
will be useful both to investigators designing new clus-
tered studies and to researchers investigating the role of
setting on patient characteristics.
Conclusion
Intra-practice correlation coefficients in this survey of
adults receiving care for diabetes varied widely. Some
characteristics (such as the likelihood of having a recent
creatinine measurement) were highly associated with the
practice (ICC = 0.288), while others (prevalence of some
comorbidities and complications and certain aspects of
quality of life) varied much more across patients with vir-
tually no correlation within practices (ICC<0.001). The
values reported here may be useful in designing future
clustered studies.
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